Bank Of Montreal

Direxion Daily Small Cap Bull 3X ETF

SPDR S&P Retail ETF

ProShares UltraPro Dow30

ProShares UltraShort Bloomberg Natrl Gas

Guggenheim Solar ETF

Direxion Technology Bear 3X Shares

Materials Select Sector SPDR

ProShares Trust ProShares Short Bitcoin Strategy ETF

ProShares Bitcoin Strategy ETF

Direxion Daily Small Cap Bear 3X ETF

ProShares Ultra Bloomberg Natural Gas

Direxion Daily Technology Bull 3X ETF

ARK Innovation ETF

Direxion Dly S&P Oil&Gs Ex&Prd Br 3X ETF

Magal Security Systems Ltd.

Direxion Financial Bear 3X Shar

Direxion Daily Semicondct Bull 3X ETF

JELD-WEN Holding Inc. Common Stock

Las Vegas Sands Corp. Common Stock

Century Communities Inc. Common Stock

Kontoor Brands Inc. Common Stock

Bath & Body Works Inc.

RLJ Lodging Trust Common Shares of Beneficial Interest $0.01 par value

Leggett & Platt Incorporated Common Stock

Snap Inc. Class A Common Stock

Cleveland-Cliffs Inc. Common Stock

Civitas Resources Inc. Common Stock

Archer Aviation Inc. Class A Common Stock

AMC Entertainment Holdings Inc. Class A Common Stock

Oklo Inc.

QuantumScape Corporation Class A Common Stock

Sea Limited American Depositary Shares each representing one Class A Ordinary Share

Cameco Corporation Common Stock

Twilio Inc. Class A Common Stock

Spotify Technology S.A. Ordinary Shares

Cloudflare Inc. Class A Common Stock

Molina Healthcare Inc Common Stock

Click here to get full coverage on How Teva Is Expanding Innovation To Fuel ‘Pivot To Growth’ - insights.citeline.com

How Teva Is Expanding Innovation To Fuel ‘Pivot To Growth’  insights.citeline.com

How Teva Is Expanding Innovation To Fuel ‘Pivot To Growth’ - insights.citeline.com

Click here to get full coverage on Teacher Retirement System of Texas Reduces Holdings in Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) - MarketBeat

Teacher Retirement System of Texas Reduces Holdings in Teva Pharmaceutical Industries Ltd. (NYSE:TEVA)  MarketBeat

Teacher Retirement System of Texas Reduces Holdings in Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) - MarketBeat

Click here to get full coverage on I Was Skeptical of This “Ugly” Sandal Brand—but Gigi Hadid and Naomi Watts Converted Me - instyle.com

I Was Skeptical of This “Ugly” Sandal Brand—but Gigi Hadid and Naomi Watts Converted Me  instyle.com

I Was Skeptical of This “Ugly” Sandal Brand—but Gigi Hadid and Naomi Watts Converted Me - instyle.com

Click here to get full coverage on Amid pricing squeeze and market withdrawals, Europe must prioritize generic manufacturing, Teva exec says - Fierce Pharma

Amid pricing squeeze and market withdrawals, Europe must prioritize generic manufacturing, Teva exec says  Fierce Pharma

Amid pricing squeeze and market withdrawals, Europe must prioritize generic manufacturing, Teva exec says - Fierce Pharma

Click here to get full coverage on We Found A Hidden Teva Sale Full Of Sandals At Up To 40% Off - Forbes

We Found A Hidden Teva Sale Full Of Sandals At Up To 40% Off  Forbes

We Found A Hidden Teva Sale Full Of Sandals At Up To 40% Off - Forbes

Click here to get full coverage on Investors in Teva Pharmaceutical Industries (NYSE:TEVA) have seen solid returns of 112% over the past three years - Yahoo Finance

Investors in Teva Pharmaceutical Industries (NYSE:TEVA) have seen solid returns of 112% over the past three years  Yahoo Finance

Investors in Teva Pharmaceutical Industries (NYSE:TEVA) have seen solid returns of 112% over the past three years - Yahoo Finance

Click here to get full coverage on Teva's Breakthrough Cancer Immunotherapy Gains Momentum with Major Asian Market Partnership - Stock Titan

Teva's Breakthrough Cancer Immunotherapy Gains Momentum with Major Asian Market Partnership  Stock Titan

Teva's Breakthrough Cancer Immunotherapy Gains Momentum with Major Asian Market Partnership - Stock Titan

Click here to get full coverage on European Commission Fines Teva €462.6 Million - McDermott Will & Emery

European Commission Fines Teva €462.6 Million  McDermott Will & Emery

European Commission Fines Teva €462.6 Million - McDermott Will & Emery

Click here to get full coverage on Teva and Fosun Pharma partner on early-stage oncology drug - PharmaTimes

Teva and Fosun Pharma partner on early-stage oncology drug  PharmaTimes

Teva and Fosun Pharma partner on early-stage oncology drug - PharmaTimes

Click here to get full coverage on While shareholders of Teva Pharmaceutical Industries (NYSE:TEVA) are in the black over 3 years, those who bought a week ago aren't so fortunate - simplywall.st

While shareholders of Teva Pharmaceutical Industries (NYSE:TEVA) are in the black over 3 years, those who bought a week ago aren't so fortunate  simplywall.st

While shareholders of Teva Pharmaceutical Industries (NYSE:TEVA) are in the black over 3 years, those who bought a week ago aren't so fortunate - simplywall.st

Click here to get full coverage on I Bought These $42 Sandals Because of the Olsen Twins, and I Can't Believe How Expensive They Look - Who What Wear

I Bought These $42 Sandals Because of the Olsen Twins, and I Can't Believe How Expensive They Look  Who What Wear

I Bought These $42 Sandals Because of the Olsen Twins, and I Can't Believe How Expensive They Look - Who What Wear

Click here to get full coverage on Susanne Georgi - La Teva Decisió (Get a Life) LIVE | Andorra 🇦🇩 | First Semi-Final | Eurovision 2009 - Eurovision Song Contest

Susanne Georgi - La Teva Decisió (Get a Life) LIVE | Andorra 🇦🇩 | First Semi-Final | Eurovision 2009  Eurovision Song Contest

Susanne Georgi - La Teva Decisió (Get a Life) LIVE | Andorra 🇦🇩 | First Semi-Final | Eurovision 2009 - Eurovision Song Contest

Click here to get full coverage on Teva to cut nearly 3000 jobs as shift from pure-play generics picks up pace - FirstWord Pharma

Teva to cut nearly 3000 jobs as shift from pure-play generics picks up pace  FirstWord Pharma

Teva to cut nearly 3000 jobs as shift from pure-play generics picks up pace - FirstWord Pharma

Click here to get full coverage on Harel Insurance Investments & Financial Services Ltd. Buys 22,044,407 Shares of Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) - MarketBeat

Harel Insurance Investments & Financial Services Ltd. Buys 22,044,407 Shares of Teva Pharmaceutical Industries Ltd. (NYSE:TEVA)  MarketBeat

Harel Insurance Investments & Financial Services Ltd. Buys 22,044,407 Shares of Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) - MarketBeat

Click here to get full coverage on Teva’s CEO shares ‘Pivot to Growth’ progress - Fierce Pharma

Teva’s CEO shares ‘Pivot to Growth’ progress  Fierce Pharma

Teva’s CEO shares ‘Pivot to Growth’ progress - Fierce Pharma

Click here to get full coverage on Straight Path Wealth Management Decreases Position in Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) - MarketBeat

Straight Path Wealth Management Decreases Position in Teva Pharmaceutical Industries Ltd. (NYSE:TEVA)  MarketBeat

Straight Path Wealth Management Decreases Position in Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) - MarketBeat

Click here to get full coverage on As Austedo, Ajovy and Uzedy gain steam, Teva banks on $5B-plus in 2030 innovative drug sales - Fierce Pharma

As Austedo, Ajovy and Uzedy gain steam, Teva banks on $5B-plus in 2030 innovative drug sales  Fierce Pharma

As Austedo, Ajovy and Uzedy gain steam, Teva banks on $5B-plus in 2030 innovative drug sales - Fierce Pharma

Click here to get full coverage on Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) Shares Bought by DAVENPORT & Co LLC - MarketBeat

Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) Shares Bought by DAVENPORT & Co LLC  MarketBeat

Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) Shares Bought by DAVENPORT & Co LLC - MarketBeat

Click here to get full coverage on WCM Investment Management LLC Increases Position in Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) - MarketBeat

WCM Investment Management LLC Increases Position in Teva Pharmaceutical Industries Ltd. (NYSE:TEVA)  MarketBeat

WCM Investment Management LLC Increases Position in Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) - MarketBeat

Click here to get full coverage on Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) Shares Purchased by Sumitomo Mitsui Trust Group Inc. - MarketBeat

Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) Shares Purchased by Sumitomo Mitsui Trust Group Inc.  MarketBeat

Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) Shares Purchased by Sumitomo Mitsui Trust Group Inc. - MarketBeat

Click here to get full coverage on Teva’s Layoffs Signal Deeper Fault Lines In The Pharma Business Model - Forbes

Teva’s Layoffs Signal Deeper Fault Lines In The Pharma Business Model  Forbes

Teva’s Layoffs Signal Deeper Fault Lines In The Pharma Business Model - Forbes

Click here to get full coverage on Zacks Industry Outlook Highlights Sandoz, Teva Pharmaceuticals and Viatris - Yahoo Finance

Zacks Industry Outlook Highlights Sandoz, Teva Pharmaceuticals and Viatris  Yahoo Finance

Zacks Industry Outlook Highlights Sandoz, Teva Pharmaceuticals and Viatris - Yahoo Finance

Click here to get full coverage on Teva Partners With Fosun to Develop TEV-56278 Immuno-Cancer Therapy - Nasdaq

Teva Partners With Fosun to Develop TEV-56278 Immuno-Cancer Therapy  Nasdaq

Teva Partners With Fosun to Develop TEV-56278 Immuno-Cancer Therapy - Nasdaq

Click here to get full coverage on Teva plots thousands of job cuts as restructuring drive enters 'acceleration' phase - Fierce Pharma

Teva plots thousands of job cuts as restructuring drive enters 'acceleration' phase  Fierce Pharma

Teva plots thousands of job cuts as restructuring drive enters 'acceleration' phase - Fierce Pharma

Click here to get full coverage on Baker McKenzie advises on US$2.3 billion bond offering for Teva Pharmaceutical and concurrent tender offer - Baker McKenzie

Baker McKenzie advises on US$2.3 billion bond offering for Teva Pharmaceutical and concurrent tender offer  Baker McKenzie

Baker McKenzie advises on US$2.3 billion bond offering for Teva Pharmaceutical and concurrent tender offer - Baker McKenzie

Click here to get full coverage on Teva Releases Essential Q2 2025 Financial Modeling Guide: Latest Insights for Investors - Stock Titan

Teva Releases Essential Q2 2025 Financial Modeling Guide: Latest Insights for Investors  Stock Titan

Teva Releases Essential Q2 2025 Financial Modeling Guide: Latest Insights for Investors - Stock Titan

Click here to get full coverage on Teva Pharmaceutical's branded drugs boost first quarter profit - Reuters

Teva Pharmaceutical's branded drugs boost first quarter profit  Reuters

Teva Pharmaceutical's branded drugs boost first quarter profit - Reuters

Click here to get full coverage on Teva Announces $2,000,000,000 (Equivalent) Debt Tender Offers For Notes Due 2026-2031 - GlobeNewswire

Teva Announces $2,000,000,000 (Equivalent) Debt Tender Offers For Notes Due 2026-2031  GlobeNewswire

Teva Announces $2,000,000,000 (Equivalent) Debt Tender Offers For Notes Due 2026-2031 - GlobeNewswire

Click here to get full coverage on Teva Pharmaceutical Industries Limited (NYSE:TEVA) Shares Purchased by Duquesne Family Office LLC - MarketBeat

Teva Pharmaceutical Industries Limited (NYSE:TEVA) Shares Purchased by Duquesne Family Office LLC  MarketBeat

Teva Pharmaceutical Industries Limited (NYSE:TEVA) Shares Purchased by Duquesne Family Office LLC - MarketBeat

Click here to get full coverage on Is Teva Pharmaceutical Industries (TEVA) the Most Undervalued Healthcare Stock to Buy According to Analysts? - Yahoo Finance

Is Teva Pharmaceutical Industries (TEVA) the Most Undervalued Healthcare Stock to Buy According to Analysts?  Yahoo Finance

Is Teva Pharmaceutical Industries (TEVA) the Most Undervalued Healthcare Stock to Buy According to Analysts? - Yahoo Finance

Click here to get full coverage on Moody's Investor Services Upgrades Teva Amid Continued Success of Pivot to Growth Strategy - GlobeNewswire

Moody's Investor Services Upgrades Teva Amid Continued Success of Pivot to Growth Strategy  GlobeNewswire

Moody's Investor Services Upgrades Teva Amid Continued Success of Pivot to Growth Strategy - GlobeNewswire

Click here to get full coverage on Final Data from Teva’s PEARL Real-World Study Reinforce the - GlobeNewswire

Final Data from Teva’s PEARL Real-World Study Reinforce the  GlobeNewswire

Final Data from Teva’s PEARL Real-World Study Reinforce the - GlobeNewswire

Click here to get full coverage on Teva Ellwood Mid Review: Boot Scootin’ - Believe in the Run

Teva Ellwood Mid Review: Boot Scootin’  Believe in the Run

Teva Ellwood Mid Review: Boot Scootin’ - Believe in the Run

Click here to get full coverage on Teva debuts global campaign encouraging people to get outside - Retail Dive

Teva debuts global campaign encouraging people to get outside  Retail Dive

Teva debuts global campaign encouraging people to get outside - Retail Dive

Click here to get full coverage on Teva Will Hike Generic Drug Prices If Trump Imposes Tariffs, CEO Says - Barron's

Teva Will Hike Generic Drug Prices If Trump Imposes Tariffs, CEO Says  Barron's

Teva Will Hike Generic Drug Prices If Trump Imposes Tariffs, CEO Says - Barron's

Click here to get full coverage on Teva Pharmaceutical Industries Ltd. to Announce Second Quarter 2025 Financial Results on July 30, 2025 - Nasdaq

Teva Pharmaceutical Industries Ltd. to Announce Second Quarter 2025 Financial Results on July 30, 2025  Nasdaq

Teva Pharmaceutical Industries Ltd. to Announce Second Quarter 2025 Financial Results on July 30, 2025 - Nasdaq

Click here to get full coverage on Lilly, J&J, Pfizer and Sanofi back Teva fight against IRA drug negotiation program - Fierce Pharma

Lilly, J&J, Pfizer and Sanofi back Teva fight against IRA drug negotiation program  Fierce Pharma

Lilly, J&J, Pfizer and Sanofi back Teva fight against IRA drug negotiation program - Fierce Pharma

Click here to get full coverage on These $42 Sandals Are Olsen-Approved and Perfect for Long Walks - ELLE

These $42 Sandals Are Olsen-Approved and Perfect for Long Walks  ELLE

These $42 Sandals Are Olsen-Approved and Perfect for Long Walks - ELLE

Click here to get full coverage on Goldman Sachs Starts Teva Pharma (TEVA) at Buy on Branded Drug Growth - Yahoo Finance

Goldman Sachs Starts Teva Pharma (TEVA) at Buy on Branded Drug Growth  Yahoo Finance

Goldman Sachs Starts Teva Pharma (TEVA) at Buy on Branded Drug Growth - Yahoo Finance

Click here to get full coverage on Teva Reports Ninth Consecutive Quarter of Growth in Q1 2025 - GlobeNewswire

Teva Reports Ninth Consecutive Quarter of Growth in Q1 2025  GlobeNewswire

Teva Reports Ninth Consecutive Quarter of Growth in Q1 2025 - GlobeNewswire

Click here to get full coverage on The Teva Turnaround: Steering a Company Comeback - PharmExec

The Teva Turnaround: Steering a Company Comeback  PharmExec

The Teva Turnaround: Steering a Company Comeback - PharmExec

Click here to get full coverage on Is Teva Pharmaceutical Industries Limited (TEVA) the Best Low Price Pharma Stock to Invest In Right Now? - Yahoo Finance

Is Teva Pharmaceutical Industries Limited (TEVA) the Best Low Price Pharma Stock to Invest In Right Now?  Yahoo Finance

Is Teva Pharmaceutical Industries Limited (TEVA) the Best Low Price Pharma Stock to Invest In Right Now? - Yahoo Finance

Click here to get full coverage on Axsome shares jump as settlement will keep Teva's Auvelity generic off the market until 2038 - Fierce Pharma

Axsome shares jump as settlement will keep Teva's Auvelity generic off the market until 2038  Fierce Pharma

Axsome shares jump as settlement will keep Teva's Auvelity generic off the market until 2038 - Fierce Pharma

Click here to get full coverage on Axsome secures top drug’s future with Teva patent settlement - BioPharma Dive

Axsome secures top drug’s future with Teva patent settlement  BioPharma Dive

Axsome secures top drug’s future with Teva patent settlement - BioPharma Dive

Click here to get full coverage on Teva Pharm CEO calls on Trump for faster US drug approvals - Reuters

Teva Pharm CEO calls on Trump for faster US drug approvals  Reuters

Teva Pharm CEO calls on Trump for faster US drug approvals - Reuters

Click here to get full coverage on Teva’s Next-Gen Trail Running Sandal Is Not Only Lighter — It’s Cheaper Too - Gear Patrol

Teva’s Next-Gen Trail Running Sandal Is Not Only Lighter — It’s Cheaper Too  Gear Patrol

Teva’s Next-Gen Trail Running Sandal Is Not Only Lighter — It’s Cheaper Too - Gear Patrol

Click here to get full coverage on Teva’s quiet layoff announcement reveals bold restructuring plan - CTech

Teva’s quiet layoff announcement reveals bold restructuring plan  CTech

Teva’s quiet layoff announcement reveals bold restructuring plan - CTech

Click here to get full coverage on Teva Trailwinder Review: Wait, it’s not a Sandal? - Believe in the Run

Teva Trailwinder Review: Wait, it’s not a Sandal?  Believe in the Run

Teva Trailwinder Review: Wait, it’s not a Sandal? - Believe in the Run

Click here to get full coverage on Chaco vs. Teva — we tested the 2 most popular hiking sandals to see how they compare - Business Insider

Chaco vs. Teva — we tested the 2 most popular hiking sandals to see how they compare  Business Insider

Chaco vs. Teva — we tested the 2 most popular hiking sandals to see how they compare - Business Insider

Click here to get full coverage on Teva Pharmaceutical Industries (TEVA): Among the Top Healthcare Stocks to Buy According to Billionaire David Einhorn - Yahoo Finance

Teva Pharmaceutical Industries (TEVA): Among the Top Healthcare Stocks to Buy According to Billionaire David Einhorn  Yahoo Finance

Teva Pharmaceutical Industries (TEVA): Among the Top Healthcare Stocks to Buy According to Billionaire David Einhorn - Yahoo Finance

Click here to get full coverage on Teva: Drugmaker Requests Delisting of Inhaler Patents from Orange Book in Response to Court Order; Boehringer Ingelheim, Novo Nordisk Have Also Asked FDA to Pull Disputed Drug-Device Patents - The Capitol Forum

Teva: Drugmaker Requests Delisting of Inhaler Patents from Orange Book in Response to Court Order; Boehringer Ingelheim, Novo Nordisk Have Also Asked FDA to Pull Disputed Drug-Device Patents  The Capitol Forum

Teva: Drugmaker Requests Delisting of Inhaler Patents from Orange Book in Response to Court Order; Boehringer Ingelheim, Novo Nordisk Have Also Asked FDA to Pull Disputed Drug-Device Patents - The Capitol Forum

Click here to get full coverage on Teva targets schizophrenia to build on innovative medicines growth - PharmaVoice

Teva targets schizophrenia to build on innovative medicines growth  PharmaVoice

Teva targets schizophrenia to build on innovative medicines growth - PharmaVoice

Click here to get full coverage on Zacks Industry Outlook Dr. Reddy's, Sandoz and Teva Pharmaceuticals - Yahoo Finance

Zacks Industry Outlook Dr. Reddy's, Sandoz and Teva Pharmaceuticals  Yahoo Finance

Zacks Industry Outlook Dr. Reddy's, Sandoz and Teva Pharmaceuticals - Yahoo Finance

Click here to get full coverage on Teva at Goldman Sachs Conference: Strategic Shift to Biopharma - Investing.com

Teva at Goldman Sachs Conference: Strategic Shift to Biopharma  Investing.com

Teva at Goldman Sachs Conference: Strategic Shift to Biopharma - Investing.com

Click here to get full coverage on How Teva Pharma Just Outmaneuvered Its Sales Miss - Investor's Business Daily

How Teva Pharma Just Outmaneuvered Its Sales Miss  Investor's Business Daily

Teva Pharma Industries Ltd ADR (TEVA)

Price Chart

Key Statistics

Technicals

About TEVA

Latest News

How Teva Is Expanding Innovation To Fuel ‘Pivot To Growth’ - insights.citeline.com

Teacher Retirement System of Texas Reduces Holdings in Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) - MarketBeat

I Was Skeptical of This “Ugly” Sandal Brand—but Gigi Hadid and Naomi Watts Converted Me - instyle.com

Environment, Social and Governance (ESG) Risk Ratings

Controversy Level

Advanced Charts

Top Gainers

Top Losers